Finanzwire Finanzwire
Basculer en Français
9751 Companies
194823 Keywords
125857 Articles
103594 Press releases
Headlines Articles Press releases HKeyBio Remove
  1. Home
  2. Companies
  3. HKeyBio
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/27/2026 at 09:40, 3 hours 35 minutes ago

    HKeyBio Unveils HKEY-AIRx™1.0 for Asthma and Allergy Drug Development

    Biotech Drug Development Asthma HKeyBio Translational Strategy
  • PRESS RELEASE

    published on 01/27/2026 at 09:35, 3 hours 40 minutes ago

    Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0

    HKeyBio introduces HKEY-AIRx™1.0, a preclinical strategy to enhance asthma and allergy drug development success by aligning disease endotypes, patient heterogeneity, and translational endpoints
    Drug Development Asthma HKeyBio Allergy Translational Reset
    Logo of HKeyBio
Accesswire
  • Published on 01/27/2026 at 13:00, 16 minutes ago

    CoTec Québec Onboards BBA To Deliver Feasibility Study, Commences Environmental Baseline Studies and Appoints Corem To Complete Metallurgical Testing Program On Lac Jeannine Iron Tailings Project

  • Published on 01/27/2026 at 13:00, 16 minutes ago

    Aztec Step-Out Drilling Extends Oxide Au/Ag Zone on Strike to +1km at Tombstone Project, Arizona; Drills 44.1m of 1.16 gpt Au and 77.7 gpt Ag (159.0 gpt AgEq) including 3.04 m of 7.5gpt Au & 465.5 gpt Ag (990.8 gpt AgEq)

  • Published on 01/27/2026 at 12:00, 1 hour 16 minutes ago

    Dynamite Blockchain Announces Major Milestone in its Digital Asset Holding

  • Published on 01/27/2026 at 12:00, 1 hour 16 minutes ago

    Prince Silver Announces $3.0 Million Non-Brokered Private Placement

  • Published on 01/27/2026 at 08:00, 5 hours 16 minutes ago

    Notification of relevant change to significant shareholder

View all ACCESSWIRE
EQS Group
  • Published on 01/27/2026 at 12:58, 17 minutes ago

    iXAfrica Data Centres Collaborates with Oracle to Deliver Kenya’s First Public Cloud Region

  • Published on 01/27/2026 at 12:19, 56 minutes ago

    EQS-Adhoc: STRABAG SE expects EBIT margin of at least 6.5% for 2025 financial year

  • Published on 01/27/2026 at 11:55, 1 hour 20 minutes ago

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

  • Published on 01/27/2026 at 11:30, 1 hour 45 minutes ago

    CHANGES TO THE BOARD OF DIRECTORS

  • Published on 01/27/2026 at 11:05, 2 hours 10 minutes ago

    Fira de Barcelona: Barcelona will connect the future of Europe's industrial energy storage in a new event

View all EQS
Les Echos
  • Published on 01/27/2026 at 12:44, 31 minutes ago

    Statement of transactions in own shares from January 19, 2026 to January 23, 2026

  • Published on 01/27/2026 at 08:00, 5 hours 16 minutes ago

    LDC : The UK Competition and Markets Authority (CMA), the competition regulatory authority in the United Kingdom, has notified LDC of the opening of a review procedure in relation to the acquisition of shares in Green Label Holdings Ltd.

  • Published on 01/27/2026 at 07:46, 5 hours 29 minutes ago

    OPmobility signs with Hyundai Mobis a Memorandum of Understanding to explore a potential acquisition of its lighting business

  • Published on 01/26/2026 at 18:00, 19 hours 15 minutes ago

    Reporting on share buyback transactions carried out between January 20 and January 21, 2026

  • Published on 01/26/2026 at 17:45, 19 hours 31 minutes ago

    Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy